Bayer Hellas

Our vision is “Health for All – Hunger for None”. Advancing life – that’s what we at Bayer are all about. We put ourselves to the test day in, day out. All together. All over the world. With enthusiasm for new ideas.

Bayer is a Life Science company with a more than 150-year history worldwide and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. In Greece, Bayer Hellas is operating since 1955, in researching (as part of the international R&D programs), developing and marketing the locally approved products of Bayer AG, in all the three divisions. Starting in 1925, the products of Bayer AG were available in the country, through local distributors.

We recognize the power of innovation in everything we do, which is why we take a holistic approach rooted in research and development, open innovation, entrepreneurship and social innovation. In line with our purpose Science for a better life, we thrive on working closely with consumers and patients to help build better products, solutions and services for a brighter tomorrow. We bring our Innovation into life, through our three divisions:

  • Pharmaceuticals
  • Consumer Health and
  • Crop Science

Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people with sales of 41,4 billion euros and R&D expenses to 4,9 billion euros.

For more information, go to

Find more about Bayer Hellas at




Managing Director

Andreas Pollner holds a Masters Degree in Economics and Business Administration from University of Witten/Herdecke, Germany and Universidad de Concepcion, Chile. Prior to joining Schering and later on Bayer, Andreas Pollner worked as an Investment Manager for the German Investment and Development Corporation leading corporate and project finance engagements in developing countries.

Andreas has gathered broad experience in the pharma market with Bayer Pharma in various leading roles in EMEA and US. As part of Bayer’s innovation path, he was leading a strategic, cross-divisional initiative to explore digital health and services in “Heart Health”. Prior to his assignment in Greece, he was heading the Therapeutic Area Cardio-Vascular for Region EMEA. He joined Bayer Hellas as Senior Bayer Representative and Cluster CDH for Pharma in Greece, Bulgaria and Romania by August 1st 2019.



Country Division Head Greece/Cyprus, Consumer Health

Andreas Kyriazis holds a Bachelor’s Degree in Operational Research and Marketing from Athens University of Economics and Business and an MBA in Finance from McGill University, Canada.

He started his career in Unilever undertaking sales and marketing managerial positions. He continued with such roles in consumer health products divisions of Novartis and later on GSK. He joined Bayer Hellas in February 2020.